Clinical Trial Update: A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing MitoQ to placebo for non-alcoholic fatty liver disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• MitoQ

Snippet

Sponsor: Antipodean Pharmaceuticals, Inc. | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2 | Status: TERMINATED